What You Should Know
- Amazon Pharmacy has officially added Novo Nordisk’s Wegovy® pill—the first and only FDA-approved oral GLP-1 for weight management—to its nationwide delivery platform.
- To lower barriers to care, Amazon is offering a transparent cash-pay option starting at $149 per month for those without insurance, while eligible commercially insured customers may pay as little as $25.
The Oral Shift: Removing the Needle Barrier
The "Wegovy pill" represents a massive
Read More
Technology
Scaling Medical Cannabinoids: How Digital Care Platforms Solve the Clinical Guidance Gap in 2026
Cannabinoids – and medical cannabis – are becoming part of the care mainstream. Evidence suggests that responsibly managed cannabinoid care and guidance can have success in symptom management, inclusive of pain, stress, anxiety, and more.
According to reports, there is no letup in sight for the growth of medical expenses and pharmaceutical utilization. Furthermore, aging populations will increase demand for chronic care, with the cost of pain management already estimated to be more than
Read More
Rewriting the Front Door: How AI-Assisted Intake Solves the 2026 Mental Health Crisis
For all the hype about AI “replacing therapists,” the more immediate and profound shift is happening somewhere far less glamorous: the intake process.
Across health systems, primary care physicians, insurers, and community providers are still funnelling patients into behavioural health through faxed referrals, phone tag, and unstructured web forms. Patients finally find the courage to ask for help, then hit voicemail, long waits, and confusing eligibility rules. In many organisations, no one
Read More
Healthconnect Texas and PCIC Unify to Build the Ultimate Social Drivers of Health (SDoH) Infrastructure
What You Should Know
- Healthconnect Texas and the Patient Care Intervention Center (PCIC) have announced a strategic unification, merging statewide clinical connectivity with deep community-based data on non-medical drivers of health.
- The unified infrastructure aims to provide a "360-degree view" of patient wellness, enabling providers and policymakers to address the 80-90% of health outcomes driven by lifestyle and environmental factors that typically live outside the Electronic
Read More
Should Brain Health Screenings Start Earlier in Adulthood?
We have traditionally been concerned about the health of the brain only after retirement, and this is a reactive approach to dealing with it, which often results in it being too late.
We should be even more concerned about memory and mental health. In the same way we are keeping track of cholesterol or blood pressure when we are in our 30s and 40s, we need to extend the same preventive thinking to our brain to enhance the long-term consequences.
Cognitive Decline Begins Earlier Than We
Read More
Who Made Your Medicine? How to Use ProPublica’s Rx Inspector to Audit Your Generics
What You Should Know
- ProPublica has released Rx Inspector, a first-of-its-kind database that allows Americans to identify the exact facility where their generic prescriptions were manufactured.
- By connecting disparate FDA databases and suing for factory location data, ProPublica has mapped more than 80% of generic products to their originating plants, revealing safety violations that the FDA has historically kept hidden from consumers.
The Shadow World of Generic
Read More
AMA’s Strategic Push for Permanent Medicare Telehealth Reform
What You Should Know
- The AMA is urging Congress to pass permanent authorization of Medicare telehealth services before the current waiver expires on January 30, 2026.
- This advocacy follows a "tumultuous" 2025 in which a 43-day government shutdown caused a 24% national drop in fee-for-service telemedicine visits, demonstrating the extreme sensitivity of patient access to legislative lapses.
The Economic Battle: Challenging CBO Scoring
The crux of the AMA’s issue brief is a
Read More
Avoiding the Telemedicine Cliff: Why the DEA Extended Prescribing Rules Through 2026
What You Should Know:
- In a significant move for the "tele-prescribing" landscape, the U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have announced a fourth temporary extension of telemedicine flexibilities.
- This extension allows practitioners to prescribe controlled medications—including Schedule II–V drugs—via audio-video encounters without a prior in-person medical evaluation through December 31, 2026.
A Transitional
Read More
Beyond Reactivity: Integrating AI-Driven Home Safety for Aging in Place
Aging in America isn’t a niche issue—it’s a seismic shift. Within five years, one in five Americans will be 65 or older. By 2034, older adults will outnumber children for the first time in U.S. history.1 This demographic flip is already reshaping households, businesses, and public policy.
One of the most urgent—and solvable—challenges is housing safety, particularly falls. Nearly 90% of older adults want to remain in their homes as they age.2 Yet, fewer than 10% of U.S. homes are
Read More
The MAHA Paradox: How Medical Device Tariffs Undermine “Make America Healthy Again
The Trump Administration’s Make America Healthy Again agenda recognizes a simple truth: the best way to improve our health is to empower people to understand and help manage their own care. Affordable medical devices make that possible.
Every day, Americans use this technology to check their blood pressure, track sleep, monitor heart rhythms, manage hearing loss, and more. These devices bring care into our homes, extend the reach of doctors, and help millions of people stay healthy
Read More
